TBRIF (Therma Bright) Debt-to-Asset : 0.02 (As of Oct. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Therma Bright Debt-to-Asset?

Therma Bright's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was $0.04 Mil. Therma Bright's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was $0.00 Mil. Therma Bright's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Oct. 2024 was $2.40 Mil. Therma Bright's debt to asset for the quarter that ended in Oct. 2024 was 0.02.

Therma Bright Debt-to-Asset Historical Data

The historical data trend for Therma Bright's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therma Bright Debt-to-Asset Chart

Therma Bright Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Debt-to-Asset

Get a 7-Day Free Trial

0.08

0.02

0.03

0.04

0.02

Therma Bright Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Debt-to-Asset	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.02

Competitive Comparison of Therma Bright's Debt-to-Asset

For the Medical Devices subindustry, Therma Bright's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Therma Bright's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Therma Bright's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Therma Bright's Debt-to-Asset falls into.

Therma Bright Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Therma Bright's Debt-to-Asset for the fiscal year that ended in Jul. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.047	+	0)	/	2.326
	=	0.02

Therma Bright's Debt-to-Asset for the quarter that ended in Oct. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.042	+	0)	/	2.399
	=	0.02

Therma Bright (OTCPK:TBRIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Therma Bright Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Therma Bright's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Therma Bright Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Therma Bright Inc (OTCPK:TBRIF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

JNX:Germany THRM:Canada

Address

345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7

Website

https://www.thermabright.com

Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.